|
1
|
Koeda K, Nishizuka S and Wakabayashi G:
Minimally invasive surgery for gastric cancer: The future standard
of care. World J Surg. 35:1469–1477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Funabiki T: Extended radical subtotal
gastrectomy with R3 lymphnodal dissection as well as saccate
bursctomy. Jpn J Gastroenterol Surg. 24:162–166. 1991. View Article : Google Scholar
|
|
3
|
Kanaya S, Haruta S, Kawamura Y, Yoshimura
F, Inaba K, Hiramatsu Y, Ishida Y, Taniguchi K, Isogaki J and Uyama
I: Video: Laparoscopy distinctive technique for suprapancreatic
lymph node dissection: Medial approach for laparoscopic gastric
cancer surgery. Surg Endosc. 25:3928–3929. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Uyama I, Suda K and Satoh S: Laparoscopic
surgery for advanced gastric cancer: Current status and future
perspectives. J Gastric Cancer. 13:19–25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu B and Lu KY: Neural invasion in
pancreatic carcinoma. Hepatobiliary Pancreat Dis Int. 1:469–476.
2002.PubMed/NCBI
|
|
6
|
Shinohara T, Satoh S, Kanaya S, Ishida Y,
Taniguchi K, Isogaki J, Inaba K, Yanaga K and Uyama I: Laparoscopic
versus open D2 gastrectomy for advanced gastric cancer: A
retrospective cohort study. Surg Endosc. 27:286–294. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liebl F, Demir IE, Mayer K, Schuster T,
D'Haese JG, Becker K, Langer R, Bergmann F, Wang K, Rosenberg R, et
al: The impact of neural invasion severity in gastrointestinal
malignancies: A clinicopathological study. Ann Surg. 260:900–907.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tanaka A, Yoshikawa H, Okuno K, Koh K,
Watatani M, Matsumura E and Yasutomi M: The importance of neural
invasion (NI) as a prognostic factor in diffuse invasive gastric
cancer. Surg Today. 27:692–695. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bilici A, Seker M, Ustaalioglu BB, Kefeli
U, Yildirim E, Yavuzer D, Aydin FM, Salepci T, Oncel M and Gumus M:
Prognostic significance of perineural invasion in patients with
gastric cancer who underwent curative resection. Ann Surg Oncol.
17:2037–2044. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Japanese Gastric Cancer Association:
Japanese Classification of gastric carcinoma: 3rd English edition.
Gastric Cancer. 14:101–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Littenberg B and MacLean CD: Passive
consent for clinical research in the age of HIPAA. J Gen Intern
Med. 21:207–211. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vellinga A, Cormican M, Hanahoe B, Bennett
K and Murphy AW: Opt-out as an acceptable method of obtaining
consent in medical research: A short report. BMC Med Res Methodol.
11:402011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sakuramoto S, Sasako M, Yamaguchi T,
Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi
Y, Imamura H, et al: Adjuvant chemotherapy for gastric cancer with
S-1, an oral fluoropyrimidine. N Engl J Med. 357:1810–1820. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Katai H, Sasako M, Fukuda H, Nakamura K,
Hiki N, Saka M, Yamaue H, Yoshikawa T and Kojima K: JCOG Gastric
Cancer Surgical Study Group: Safety and feasibility of
laparoscopy-assisted distal gastrectomy with suprapancreatic nodal
dissection for clinical stage I gastric cancer: A multicenter phase
II trial (JCOG 0703). Gastric Cancer. 13:238–244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim HI, Hur H, Kim YN, Lee HJ, Kim MC, Han
SU and Hyung WJ: Standardization of D2 lymphadenectomy and surgical
quality control (KLASS-02-QC): A prospective, observational,
multicenter study [NCT01283893]. BMC Cancer. 14:2092014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fukunaga T, Hiki N, Kubota T, Nunobe S,
Tokunaga M, Nohara K, Sano T and Yamaguchi T: Oncologic outcomes of
laparoscopy-assisted distal gastrectomy for gastric cancer. Ann
Surg Oncol. 20:2676–2682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Facchetti F, Lonardi S, Gentili F, Bercich
L, Falchetti M, Tardanico R, Baronchelli C, Lucini L, Santin A and
Murer B: Claudin 4 identifies a wide spectrum of epithelial
neoplasms and represents a very useful marker for carcinoma versus
mesothelioma diagnosis in pleural and peritoneal biopsies and
effusions. Virchows Arch. 451:669–680. 2007. View Article : Google Scholar : PubMed/NCBI
|
